Valuation : genedrive plc

Market Cap 20.87M 28.21M 24.28M 22.85M 39.03M 2.67B 39.15M 270M 104M 1.37B 106M 104M 4.41B P/E 2024
-0.35x
P/E 2025 -1.51x
Enterprise Value 19.69M 26.61M 22.91M 21.55M 36.82M 2.51B 36.93M 255M 98.39M 1.29B 99.85M 97.72M 4.16B EV / Sales 2024
7.57x
EV / Sales 2025 7.93x
Free-Float
36.41%
Yield 2024 *
-
Yield 2025 -
1 week-1.79%
Current month-1.79%
1 month+19.57%
3 months+3.77%
6 months+29.72%
Current year+57.14%
1 week 1.3
Extreme 1.3
1.55
1 month 1.12
Extreme 1.115
1.55
Current year 0.75
Extreme 0.75
1.55
1 year 0.19
Extreme 0.19
1.55
3 years 0.19
Extreme 0.19
13.5
5 years 0.19
Extreme 0.19
82
10 years 0.19
Extreme 0.19
302.6
Manager TitleAgeSince
Chief Executive Officer 56 2024-08-05
Director of Finance/CFO 48 2022-04-06
Director TitleAgeSince
Director/Board Member 69 2018-04-08
Director/Board Member 52 2018-08-21
Director/Board Member 56 2023-09-10
Date Insider Type Main position Quantity % Market Cap. Importance
12/20/24 Buy

Chief Financial Officer

1,000,000 0.1841%
12/20/24 Free 400,000 0.0736%
12/20/24 Buy

Chief Executive Officer

1,135,208 0.2090%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-1.79%+223.53%-87.78% 29.85M
-3.10%-6.43%+22.77%-34.89% 17.14B
+1.73%+0.74%-34.27%+56.78% 1.66B
+0.29%-5.22%-51.29%-82.59% 958M
+0.47%-2.95%-21.17%+16.47% 934M
-0.05%+0.05%+58.88%-3.84% 780M
+0.09%-0.27%-32.81%-47.72% 672M
+0.33%+9.28%-35.36%-43.39% 619M
-1.01%+4.67%-32.99%-31.35% 530M
+0.10%-6.34%+84.74%+48.01% 415M
Average -0.12%-1.15%+18.20%-21.03% 2.37B
Weighted average by Cap. -2.10%-4.64%+12.25%-26.47%

Financials

2024 2025
Net sales 501K 677K 583K 548K 937K 63.97M 940K 6.48M 2.5M 32.8M 2.54M 2.49M 106M 954K 1.29M 1.11M 1.04M 1.78M 122M 1.79M 12.34M 4.77M 62.45M 4.84M 4.73M 201M
Net income -7.08M -9.56M -8.23M -7.74M -13.23M -903M -13.27M -91.5M -35.35M -463M -35.88M -35.11M -1.49B -5.23M -7.07M -6.09M -5.73M -9.78M -668M -9.81M -67.66M -26.14M -342M -26.53M -25.96M -1.1B
Net Debt -5.17M -6.99M -6.01M -5.66M -9.66M -660M -9.69M -66.85M -25.83M -338M -26.21M -25.65M -1.09B -1.18M -1.6M -1.38M -1.29M -2.21M -151M -2.22M -15.29M -5.91M -77.38M -5.99M -5.87M -250M
Logo genedrive plc
genedrive plc is a United Kingdom-based pharmacogenetic testing company. The Company is engaged in developing and commercializing a rapid, versatile, simple to use and robust point-of-need pharmacogenetic platform for the diagnosis of genetic variations. The Company’s products include Genedrive MT-RNR1 ID Kit, Genedrive System, and Genedrive CYP2C19 ID Kit. The Company’s flagship product Genedrive MT-RNR1 ID Kit is a single-use disposable cartridge that circumvents the requirement for cold chain logistics by providing temperature stable reagent test kits for use on their proprietary test platform. The Genedrive System is a rapid thermocycler and signal detection system, enabling PCR and isothermal based amplification techniques. It is a semi- automated system used for qualitative in vitro molecular diagnostic tests. Its Genedrive CYP2C19 ID Kit Molecular point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings.
Employees
43
Date Price Change Volume
26-09-04 GBX 1.375 0.00% 1,612,694
26-09-03 GBX 1.375 0.00% 11,258,889
26-09-02 GBX 1.375 -1.79% 1,115,429
26-09-01 GBX 1.400 0.00% 10,964,144

Annual profits - Rate of surprise